Pituitary somatostatin receptor signaling

被引:151
作者
Ben-Shlomo, Anat [1 ]
Melmed, Shlomo [1 ]
机构
[1] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA
关键词
GROWTH-HORMONE-SECRETION; RAT ANTERIOR-PITUITARY; INTRACELLULAR FREE CALCIUM; MESSENGER-RNA EXPRESSION; ADENOMAS IN-VITRO; GENE-EXPRESSION; TUMOR-CELLS; QUANTITATIVE-ANALYSIS; PROLACTIN SECRETION; CUSHINGS-DISEASE;
D O I
10.1016/j.tem.2009.12.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Somatotropin-release inhibitory factor (SRIF) is a major regulator of pituitary function, mostly inhibiting hormone secretion and to a lesser extent pituitary cell growth. Five SRIF receptor subtypes (SSTR1-5) are ubiquitously expressed G-protein coupled receptors. In the pituitary, SSTR1, 2, 3 and 5 are expressed, with SSTR2 and SSTR5 predominating. As new SRIF analogs have recently been introduced for treatment of pituitary disease, we evaluate the current knowledge of cell-specific pituitary SRIF receptor signaling and highlight areas of future research for comprehensive understanding of these mechanisms. Elucidating pituitary SRIF receptor signaling enables understanding of pituitary hormone secretion and cell growth, and also encourages future therapeutic development for pituitary disorders.
引用
收藏
页码:123 / 133
页数:11
相关论文
共 144 条
  • [1] Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas
    Acunzo, Julie
    Thirion, Sylvie
    Roche, Catherine
    Saveanu, Alexandru
    Gunz, Ginette
    Germanetti, Anne Laure
    Couderc, Bettina
    Cohen, Richard
    Figarella-Branger, Dominique
    Dufour, Henry
    Brue, Thierry
    Enjalbert, Alain
    Barlier, Anne
    [J]. CANCER RESEARCH, 2008, 68 (24) : 10163 - 10170
  • [2] MEASUREMENT OF GROWTH-HORMONE SYNTHESIS BY RAT PITUITARY CELLS IN CULTURE
    BANCROFT, FC
    [J]. ENDOCRINOLOGY, 1973, 92 (04) : 1014 - 1021
  • [3] The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas
    Batista, Dalia L.
    Zhang, Xun
    Gejman, Roger
    Ansell, Peter J.
    Zhou, Yunli
    Johnson, Sarah A.
    Swearingen, Brooke
    Hedley-Whyte, E. Tessa
    Stratakis, Constantine A.
    Klibanski, Anne
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) : 4482 - 4488
  • [4] Beck-Peccoz Paolo, 2002, Pituitary, V5, P83
  • [5] Somatostatin receptor type 5 modulates somatostatin receptor type 2 regulation of adrenocorticotropin secretion
    Ben-Shlomo, A
    Wawrowsky, KA
    Proekt, I
    Wolkenfeld, NM
    Ren, SG
    Taylor, J
    Culler, MD
    Melmed, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (25) : 24011 - 24021
  • [6] Somatostatin agonists for treatment of acromegaly
    Ben-Shlomo, Anat
    Melmed, Shlomo
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 286 (1-2) : 192 - 198
  • [7] Selective regulation of somatostatin receptor subtype signaling: Evidence for constitutive receptor activation
    Ben-Shlomo, Anat
    Pichurin, Oxana
    Barshop, Nicole J.
    Wawrowsky, Kolja A.
    Taylor, John
    Culler, Michael D.
    Chesnokova, Vera
    Liu, Ning-Ai
    Melmed, Shlomo
    [J]. MOLECULAR ENDOCRINOLOGY, 2007, 21 (10) : 2565 - 2578
  • [8] Ben-Shlomo A, 2007, IDRUGS, V10, P885
  • [9] Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
    Ben-Shlomo, Anat
    Schmid, Herbert
    Wawrowsky, Kolja
    Pichurin, Oxana
    Hubina, Erika
    Chesnokova, Vera
    Liu, Ning-Ai
    Culler, Michael
    Melmed, Shlomo
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (11) : 4342 - 4350
  • [10] Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response
    Ben-Shlomo, Anat
    Zhou, Cuiqi
    Pichurin, Oxana
    Chesnokova, Vera
    Liu, Ning-Ai
    Culler, Michael D.
    Melmed, Shlomo
    [J]. MOLECULAR ENDOCRINOLOGY, 2009, 23 (03) : 337 - 348